Organovo Holdings Inc (ONVO)
0.40
+0.05
(+14.32%)
USD |
NASDAQ |
Nov 22, 16:00
0.395
0.00 (0.00%)
After-Hours: 20:00
Organovo Holdings Profit Margin (Quarterly): -8.50K% for Sept. 30, 2024
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
Date | Value |
---|---|
September 30, 2024 | -8.50K% |
June 30, 2024 | -8.57K% |
March 31, 2024 | -10.50K% |
December 31, 2023 | -72.08K% |
September 30, 2023 | |
June 30, 2023 | -5.37K% |
March 31, 2023 | -4.60K% |
December 31, 2022 | -2.49K% |
September 30, 2022 | -4.31K% |
June 30, 2022 | |
March 31, 2022 | -127.4% |
December 31, 2021 | |
September 30, 2021 | |
June 30, 2021 | |
March 31, 2021 | |
December 31, 2020 | |
September 30, 2020 | |
June 30, 2020 | |
March 31, 2020 | |
December 31, 2019 | -1.13K% |
September 30, 2019 | -511.7% |
June 30, 2019 | -946.6% |
March 31, 2019 | -1.03K% |
December 31, 2018 | -821.4% |
September 30, 2018 | -619.0% |
Date | Value |
---|---|
June 30, 2018 | -1.08K% |
March 31, 2018 | -674.1% |
December 31, 2017 | -675.7% |
September 30, 2017 | -698.2% |
June 30, 2017 | -1.02K% |
March 31, 2017 | -1.31K% |
December 31, 2016 | -832.4% |
September 30, 2016 | -686.2% |
June 30, 2016 | -984.0% |
March 31, 2016 | -1.53K% |
December 31, 2015 | -3.19K% |
September 30, 2015 | -3.74K% |
June 30, 2015 | -2.77K% |
March 31, 2015 | -2.92K% |
December 31, 2014 | -4.51K% |
September 30, 2014 | -17.72K% |
June 30, 2014 | -6.50K% |
March 31, 2014 | -5.64K% |
December 31, 2013 | -3.86K% |
September 30, 2013 | -45.16K% |
June 30, 2013 | -3.56K% |
December 31, 2012 | -2.74K% |
September 30, 2012 | |
June 30, 2012 | -13.66K% |
March 31, 2012 | -30.90K% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-72.08K%
Minimum
Dec 2023
-127.4%
Maximum
Mar 2022
-11.77K%
Average
-4.99K%
Median
Profit Margin (Quarterly) Benchmarks
CEL-SCI Corp | -- |
AIM ImmunoTech Inc | -10.57K% |
IGC Pharma Inc | -416.7% |
NovaBay Pharmaceuticals Inc | -49.65% |
Protalix BioTherapeutics Inc | 18.02% |
Profit Margin (Quarterly) Related Metrics
Return on Equity | -219.4% |
Return on Assets | -147.2% |
Return on Invested Capital | -219.4% |
Gross Profit Margin (Quarterly) | 96.67% |
Operating Margin (Quarterly) | -8.69K% |
Return on Net Operating Assets | -518.6% |